Senju Settles Out Of Apotex's Pinkeye Meds Antitrust Suit
Apotex has reached a settlement to resolve its claims against Senju Pharmaceutical in an antitrust suit accusing multiple drugmakers of trying to extend the patent for Allergan Inc.'s Zymar pinkeye treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article